Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

β(1)-adrenergic receptor polymorphisms and response to β-blockade in the African-American study of kidney disease and hypertension (AASK).

American journal of hypertension - 1 Jun 2011

Lee Jason, Aziz Hossein, Liu Lin, Lipkowitz Michael, O'Connor Daniel T, Richard Erin, Brophy Victoria, Wassel Christina L, Blantz Roland, Bhatnagar Vibha

Abstract excerpt

BACKGROUND: This study focuses on the relationship between β(1)-adrenergic receptor (ADRB1) polymorphisms and blood pressure response to the β-blocker metoprolol among African Americans with early hypertensive nephrosclerosis. METHODS: Participants from the African-American Study of Kidney Disease and Hypertension (AASK) trial were genotyped for ADRB1 polymorphisms: Ser49Gly and Arg389Gly. Cox proportional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Antagonists
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Pressure

Share to Genotype

Share to Hypertension

Share to Metoprolol

Share to Obesity

Share to Receptors, Adrenergic, beta-1

Source

Identifiers

PMID: 21415838
DOI: 10.1038/ajh.2011.39

Genes

ADRB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

β(1)-adrenergic receptor polymorphisms and response to β-blockade in the African-American study of kidney disease and hypertension (AASK).PMID 21415838Read ↗

G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.Semantic proximity Read ↗

Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis.Semantic proximity Read ↗

Relationship between beta1-adrenergic receptor polymorphisms and cardiovascular disease in patients with diabetic nephropathy.Semantic proximity Read ↗

The Beta-Blocker Pharmacogenetic Puzzle: More Pieces of Evidence for Pharmacodynamic Candidate Variants.Semantic proximity Read ↗

Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.Semantic proximity Read ↗

The importance of G protein-coupled receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment.Semantic proximity Read ↗

Genome-Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β-Blockers.Semantic proximity Read ↗

A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade.Semantic proximity Read ↗

β-Adrenergic receptor gene polymorphism is a genetic risk factor for cardiovascular disease: a cohort study with hypertensive patients.Semantic proximity Read ↗

Pharmacogenomics of β-adrenergic receptor physiology and response to β-blockade.Semantic proximity Read ↗

Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans.Semantic proximity Read ↗

Effects of sex and the common ADRB1 389 genetic polymorphism on the hemodynamic response to dobutamine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.